Any entrepreneur worth their salt realizes that being savvy in their chosen line of business is first priority.
However, one would be hard-pressed to find any individual with the same pedigree of skill and understanding as Cameron Clokie, particularly in a field few others have even noticed at this point in time. Learn more about Cameron Clokie: https://ca.linkedin.com/in/dr-cameron-clokie-136991109
Earning a Doctorate of Dental Surgery in 1985, Cameron Clokie’s began his practice in the field of facial reconstruction, which later earned him the title of Head of Oral and Maxillofacial Surgery at the University of Toronto.
Impressive prestige to be sure, but what makes Cameron Clokie an entrepreneur is his interest in the field of regenerative medicine, particularly in bone regeneration, a near-untapped field of study.
According to Crunchbase, to that end Cameron Clokie later received a Ph.D in bone regeneration from McGill University, where he later established his bone research group in 1993.
This group led Cameron Clokie to become the CEO of Induce Biologics Inc., a regenerative medicine company focused on musculoskeletal reconstruction.
Clokie now plies his trade in researching new bone regenerative technologies, the ultimate goal being the development of bioimplants, which would replace the need for autogenous bone graphs, particularly in facial reconstruction, hence his pursuit of a degree in oral care.
He also sports extensive experience taken from serving on scientific divisions for several companies as well as lecturing internationally and submitting content to various publications on the subject of regenerative medicine.
The world of regenerative medicine is still largely uncharted, and to pursue it demands taking a chance to branch out into the unknown, a proposition daunting enough to turn many away.
However, Cameron Clokie understands that a new frontier of study comes with great risks but even greater rewards, a revolution in medicine that would undoubtedly benefit all involved.